MUCL1 and breast carcinoma: These results suggested that miR-186-5p could degrade SBEM to regulate the PI3K/AKT signaling pathway, and exogenous overexpression of miR-186-5p could significantly inhibit the phosphorylation of proteins related to the PI3K/AKT signaling pathway and the migration and invasive ability of breast cancer cells.